PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| prothioconazole (ISO); 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione | 605-841-2 | 178928-70-6 | - | - | - | - | - | 1 | - | - | - | Details |
| Proxan-sodium | 205-443-5 | 140-93-2 | - | - | 1 | - | - | - | - | - | - | Details |
| PURAM | 434-000-0 | - | - | - | - | - | 1 | - | - | - | - | Details |
| Purine-2(3H),6(1H)-dione | 200-718-6 | 69-89-6 | - | - | - | - | 1 | - | - | - | - | Details |
| pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one | 602-927-1 | 123312-89-0 | - | - | - | - | - | 1 | - | - | - | Details |
| Pyraclostrobin | 605-747-1 | 175013-18-0 | - | - | - | - | - | 1 | - | - | - | Details |
| Pyrazole | 206-017-1 | 288-13-1 | - | - | - | - | 1 | - | - | - | - | Details |
| pyridalyl (ISO); 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether | 605-845-4 | 179101-81-6 | - | - | - | - | - | 1 | - | - | - | Details |
| Pyridazine-3,6-diol | 204-619-9 | 123-33-1 | - | - | - | - | - | 1 | - | - | - | Details |
| Pyridine | 203-809-9 | 110-86-1 | - | - | 3 | - | - | - | - | - | - | Details |